George Elston, Chief Financial Officer at EyePoint Pharmaceuticals, Inc. (EYPT), bought 10,000 shares at $1.43 ($14K) on 2019-11-15, disclosed to the SEC on 2019-11-18.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |
| EYPT | BUY | 2020-03-13 | $10K | — | Filing → |
| JNP | BUY | 2016-08-31 | $6K | — | Filing → |